Skip to main content
. 2021 Aug 6;9(8):875. doi: 10.3390/vaccines9080875

Figure 1.

Figure 1

Ex vivo ELISpot assay for VZV-specific T-cell response. VZV-specific T-cell response to gE and IE63 35 VZV-seropositive healthy subjects and 7 VZV-seronegative healthy subjects. The cut-off of positive responses was calculated as the mean of the response in VZV-seronegative subjects plus two standard deviations. Ctrl: Ex vivo ELISpot assay measured against medium only.